JP6889772B2 - 噴霧チャンバ及びそれらを利用する方法 - Google Patents
噴霧チャンバ及びそれらを利用する方法 Download PDFInfo
- Publication number
- JP6889772B2 JP6889772B2 JP2019512942A JP2019512942A JP6889772B2 JP 6889772 B2 JP6889772 B2 JP 6889772B2 JP 2019512942 A JP2019512942 A JP 2019512942A JP 2019512942 A JP2019512942 A JP 2019512942A JP 6889772 B2 JP6889772 B2 JP 6889772B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- outer chamber
- chamber
- spray chamber
- spray
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007921 spray Substances 0.000 title claims description 252
- 239000006199 nebulizer Substances 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 26
- 230000008021 deposition Effects 0.000 claims description 9
- 230000007423 decrease Effects 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 description 382
- 239000007789 gas Substances 0.000 description 93
- 239000000523 sample Substances 0.000 description 71
- 229960004316 cisplatin Drugs 0.000 description 49
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 49
- 238000000034 method Methods 0.000 description 41
- 230000006698 induction Effects 0.000 description 37
- 239000010931 gold Substances 0.000 description 34
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 31
- 229910052737 gold Inorganic materials 0.000 description 31
- 150000002500 ions Chemical class 0.000 description 29
- 239000002245 particle Substances 0.000 description 28
- 239000012530 fluid Substances 0.000 description 27
- 241000894007 species Species 0.000 description 27
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 25
- 229910052751 metal Inorganic materials 0.000 description 21
- 239000002184 metal Substances 0.000 description 21
- 239000002105 nanoparticle Substances 0.000 description 21
- 230000003248 secreting effect Effects 0.000 description 18
- 238000010521 absorption reaction Methods 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 14
- 210000002569 neuron Anatomy 0.000 description 14
- 210000000130 stem cell Anatomy 0.000 description 14
- 238000001636 atomic emission spectroscopy Methods 0.000 description 12
- 230000008901 benefit Effects 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 238000000151 deposition Methods 0.000 description 12
- 238000001514 detection method Methods 0.000 description 12
- 210000004907 gland Anatomy 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 11
- 238000004949 mass spectrometry Methods 0.000 description 11
- 210000002919 epithelial cell Anatomy 0.000 description 10
- 238000009616 inductively coupled plasma Methods 0.000 description 10
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 10
- 210000004962 mammalian cell Anatomy 0.000 description 10
- 230000003287 optical effect Effects 0.000 description 10
- 238000010586 diagram Methods 0.000 description 9
- 241000195493 Cryptophyta Species 0.000 description 8
- 206010033128 Ovarian cancer Diseases 0.000 description 8
- 206010061535 Ovarian neoplasm Diseases 0.000 description 8
- 239000000443 aerosol Substances 0.000 description 8
- 210000002985 organ of corti Anatomy 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 235000003642 hunger Nutrition 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 230000032258 transport Effects 0.000 description 7
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 150000002739 metals Chemical class 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 229910052697 platinum Inorganic materials 0.000 description 6
- 230000037351 starvation Effects 0.000 description 6
- 210000000270 basal cell Anatomy 0.000 description 5
- 230000022131 cell cycle Effects 0.000 description 5
- 230000009977 dual effect Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 238000011068 loading method Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 238000004088 simulation Methods 0.000 description 5
- NYQDCVLCJXRDSK-UHFFFAOYSA-N Bromofos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(Br)C=C1Cl NYQDCVLCJXRDSK-UHFFFAOYSA-N 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 238000000889 atomisation Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 210000004498 neuroglial cell Anatomy 0.000 description 4
- 108091008695 photoreceptors Proteins 0.000 description 4
- 210000002248 primary sensory neuron Anatomy 0.000 description 4
- 239000010453 quartz Substances 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 210000004918 root sheath Anatomy 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 210000002363 skeletal muscle cell Anatomy 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 230000001720 vestibular Effects 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 210000003969 blast cell Anatomy 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000000451 chemical ionisation Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 210000003981 ectoderm Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001900 endoderm Anatomy 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000012737 fresh medium Substances 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000003714 granulocyte Anatomy 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 210000002768 hair cell Anatomy 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000005265 lung cell Anatomy 0.000 description 3
- 210000002596 lutein cell Anatomy 0.000 description 3
- 210000003716 mesoderm Anatomy 0.000 description 3
- 230000009456 molecular mechanism Effects 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 230000001254 nonsecretory effect Effects 0.000 description 3
- 230000031868 operant conditioning Effects 0.000 description 3
- 230000002611 ovarian Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000002105 tongue Anatomy 0.000 description 3
- 210000001635 urinary tract Anatomy 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 230000033616 DNA repair Effects 0.000 description 2
- 102400000321 Glucagon Human genes 0.000 description 2
- 108060003199 Glucagon Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000002255 anal canal Anatomy 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000001011 carotid body Anatomy 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000004568 cement Substances 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000000132 electrospray ionisation Methods 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 210000003499 exocrine gland Anatomy 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000003325 follicular Effects 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000001434 glomerular Effects 0.000 description 2
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 2
- 229960004666 glucagon Drugs 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 210000004024 hepatic stellate cell Anatomy 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004153 islets of langerhan Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 210000004699 muscle spindle Anatomy 0.000 description 2
- 108091008709 muscle spindles Proteins 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 210000002955 secretory cell Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000002325 somatostatin-secreting cell Anatomy 0.000 description 2
- 210000004500 stellate cell Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 238000004627 transmission electron microscopy Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 108010051479 Bombesin Proteins 0.000 description 1
- 102000013585 Bombesin Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- -1 Gibco TM) Substances 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 101710108470 Hyalin Proteins 0.000 description 1
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 1
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000003752 Lipocalin 1 Human genes 0.000 description 1
- 108010057281 Lipocalin 1 Proteins 0.000 description 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Natural products O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 102000018886 Pancreatic Polypeptide Human genes 0.000 description 1
- 102100024819 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N Serotonin Natural products C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 101000983124 Sus scrofa Pancreatic prohormone precursor Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 210000005058 airway cell Anatomy 0.000 description 1
- 210000001132 alveolar macrophage Anatomy 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004198 anterior pituitary gland Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000004082 barrier epithelial cell Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000000906 capillary electrophoresis-inductively coupled plasma mass spectrometry Methods 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 190000008236 carboplatin Chemical compound 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 210000003239 corneal fibroblast Anatomy 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 210000005168 endometrial cell Anatomy 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000003426 epidermal langerhans cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000004904 fingernail bed Anatomy 0.000 description 1
- 210000004186 follicle cell Anatomy 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000002406 gastrin-secreting cell Anatomy 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 210000004565 granule cell Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 208000002557 hidradenitis Diseases 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000000091 laser ablation electrospray ionisation Methods 0.000 description 1
- 238000001698 laser desorption ionisation Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229910001338 liquidmetal Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 210000000716 merkel cell Anatomy 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003550 mucous cell Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000000581 natural killer T-cell Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000001577 neostriatum Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000001915 nurse cell Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000001706 olfactory mucosa Anatomy 0.000 description 1
- 210000001517 olfactory receptor neuron Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 229960001756 oxaliplatin Drugs 0.000 description 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000002705 pancreatic stellate cell Anatomy 0.000 description 1
- 230000000849 parathyroid Effects 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002263 peptidergic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000004332 phalangeal cell Anatomy 0.000 description 1
- 210000000608 photoreceptor cell Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000000449 purkinje cell Anatomy 0.000 description 1
- 210000002763 pyramidal cell Anatomy 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000000717 sertoli cell Anatomy 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000001057 smooth muscle myoblast Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000000672 surface-enhanced laser desorption--ionisation Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000004906 toe nail Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 210000002395 vitreous cell Anatomy 0.000 description 1
- 210000001849 von ebner gland Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000000636 white adipocyte Anatomy 0.000 description 1
Images
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/10—Ion sources; Ion guns
- H01J49/107—Arrangements for using several ion sources
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/04—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components
- H01J49/0431—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components for liquid samples
- H01J49/0445—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components for liquid samples with means for introducing as a spray, a jet or an aerosol
- H01J49/045—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components for liquid samples with means for introducing as a spray, a jet or an aerosol with means for using a nebulising gas, i.e. pneumatically assisted
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
- G01N30/7273—Desolvation chambers
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/04—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components
- H01J49/0468—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components with means for heating or cooling the sample
- H01J49/049—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components with means for heating or cooling the sample with means for applying heat to desorb the sample; Evaporation
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/10—Ion sources; Ion guns
- H01J49/16—Ion sources; Ion guns using surface ionisation, e.g. field-, thermionic- or photo-emission
- H01J49/165—Electrospray ionisation
- H01J49/167—Capillaries and nozzles specially adapted therefor
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/10—Ion sources; Ion guns
- H01J49/105—Ion sources; Ion guns using high-frequency excitation, e.g. microwave excitation, Inductively Coupled Plasma [ICP]
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Plasma & Fusion (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Electron Tubes For Measurement (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Plasma Technology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662337997P | 2016-05-18 | 2016-05-18 | |
| US62/337,997 | 2016-05-18 | ||
| PCT/US2017/033063 WO2017201143A1 (en) | 2016-05-18 | 2017-05-17 | Spray chambers and methods of using them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019521366A JP2019521366A (ja) | 2019-07-25 |
| JP2019521366A5 JP2019521366A5 (https=) | 2020-06-25 |
| JP6889772B2 true JP6889772B2 (ja) | 2021-06-18 |
Family
ID=60326194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019512942A Expired - Fee Related JP6889772B2 (ja) | 2016-05-18 | 2017-05-17 | 噴霧チャンバ及びそれらを利用する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US10147592B2 (https=) |
| EP (1) | EP3459323A4 (https=) |
| JP (1) | JP6889772B2 (https=) |
| KR (1) | KR102042436B1 (https=) |
| CN (1) | CN109964541B (https=) |
| AU (1) | AU2017268310B8 (https=) |
| CA (1) | CA3024740A1 (https=) |
| WO (1) | WO2017201143A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10804091B2 (en) * | 2016-05-18 | 2020-10-13 | Perkinelmer Health Sciences Canada, Inc. | Single particle analysis using optical detection |
| KR102288662B1 (ko) * | 2017-05-12 | 2021-08-10 | 가부시키가이샤 사무코 | 스프레이 챔버, 시료 안개화 도입 장치, 분석 장치 및 시료 중의 성분 분석 방법 |
| US11630039B1 (en) * | 2018-08-07 | 2023-04-18 | Elemental Scientific, Inc. | Spray chamber having dual input ports for impingement gas and sensitivity enhancement gas addition |
| US11075066B2 (en) * | 2018-10-26 | 2021-07-27 | Agilent Technologies, Inc. | Automated detection of nanoparticles using single-particle inductively coupled plasma mass spectrometry (SP-ICP-MS) |
| WO2020150126A1 (en) * | 2019-01-14 | 2020-07-23 | Agilent Technologies, Inc. | Versatile tube-free jet for gc detector |
| AU2020218788B2 (en) * | 2019-02-04 | 2025-06-26 | Glass Expansion Pty. Limited | Analytic nebuliser |
| EP3949694B1 (en) * | 2019-04-01 | 2025-04-30 | Perkinelmer Health Sciences Canada, Inc. | Devices and methods to improve background equivalent concentrations of elemental species |
| KR102137911B1 (ko) * | 2019-09-16 | 2020-07-27 | 강원대학교산학협력단 | 형질전환 정원줄기세포의 생산방법 |
| CN113237942B (zh) * | 2021-05-07 | 2023-09-26 | 上海科技大学 | 在微量细胞中检测多种微量元素的方法及应用 |
| KR102571890B1 (ko) * | 2021-11-29 | 2023-08-30 | 한국생산기술연구원 | 표면증폭 라만산란을 위한 금속나노입자 수집장치 |
| EP4258323A1 (en) * | 2022-04-08 | 2023-10-11 | Glass Expansion Pty. Limited | A flow control device |
| WO2025133161A1 (en) * | 2023-12-20 | 2025-06-26 | Thermo Fisher Scientific (Bremen) Gmbh | Connecting element for spectrometry |
| CN121612864B (zh) * | 2026-02-02 | 2026-04-24 | 上海车仪田科技有限公司 | 光学传感器、光谱检测系统及半导体工艺设备 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4990740A (en) * | 1989-03-06 | 1991-02-05 | The Dow Chemical Company | Intra-microspray ICP torch |
| US5012065A (en) | 1989-11-20 | 1991-04-30 | New Mexico State University Technology Transfer Corporation | Inductively coupled plasma torch with laminar flow cooling |
| US4958529A (en) * | 1989-11-22 | 1990-09-25 | Vestec Corporation | Interface for coupling liquid chromatography to solid or gas phase detectors |
| JP2633974B2 (ja) * | 1990-04-18 | 1997-07-23 | 株式会社日立製作所 | 試料のイオン化および質量分析のための装置 |
| EP0560537A1 (en) * | 1992-03-10 | 1993-09-15 | Mds Health Group Limited | Apparatus and method for liquid sample introduction |
| JP2852838B2 (ja) * | 1992-09-10 | 1999-02-03 | セイコーインスツルメンツ株式会社 | 誘導結合プラズマ質量分析装置 |
| US5868322A (en) * | 1996-01-31 | 1999-02-09 | Hewlett-Packard Company | Apparatus for forming liquid droplets having a mechanically fixed inner microtube |
| EP1012871A1 (en) | 1997-01-03 | 2000-06-28 | MDS Inc. | Spray chamber with dryer |
| US5969352A (en) * | 1997-01-03 | 1999-10-19 | Mds Inc. | Spray chamber with dryer |
| JPH11326165A (ja) * | 1998-05-18 | 1999-11-26 | Yokogawa Analytical Systems Inc | 試料液の霧化導入装置 |
| JP3836693B2 (ja) * | 2001-07-30 | 2006-10-25 | 独立行政法人科学技術振興機構 | Ｉｃｐ質量分析用クロスフロー型マイクロネブライザー |
| JP3809099B2 (ja) * | 2001-12-12 | 2006-08-16 | 株式会社堀場製作所 | 乾式粒径分布測定装置 |
| JP2006038729A (ja) | 2004-07-29 | 2006-02-09 | National Institute Of Advanced Industrial & Technology | 誘導結合プラズマトーチ |
| US20070023677A1 (en) | 2005-06-29 | 2007-02-01 | Perkins Patrick D | Multimode ionization source and method for screening molecules |
| JP2008157895A (ja) * | 2006-12-26 | 2008-07-10 | Horiba Ltd | 試料導入装置 |
| US7595487B2 (en) * | 2007-08-24 | 2009-09-29 | Georgia Tech Research Corporation | Confining/focusing vortex flow transmission structure, mass spectrometry systems, and methods of transmitting particles, droplets, and ions |
| US8440063B2 (en) | 2008-03-26 | 2013-05-14 | Massachusetts Institute Of Technology | Electrokinetic concentration devices |
| KR101089328B1 (ko) | 2009-12-29 | 2011-12-02 | 한국기초과학지원연구원 | 전기분무 이온화 장치 및 이를 이용한 전기분무 이온화 방법 |
| WO2011127417A2 (en) * | 2010-04-09 | 2011-10-13 | Elemental Scientific, Inc. | Torch assembly |
| US8963076B2 (en) * | 2011-10-26 | 2015-02-24 | Fluidigm Canada Inc. | Sample transferring apparatus for mass cytometry |
| CN103762150B (zh) * | 2014-01-27 | 2016-03-30 | 中国科学技术大学 | 超声雾化进样的挥发溶剂辅助电离低压光电离质谱装置 |
| JP6698026B2 (ja) | 2014-01-28 | 2020-05-27 | パーキンエルマー・ヘルス・サイエンシーズ・インコーポレイテッドＰｅｒｋｉｎｅｌｍｅｒ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． | 誘導装置及びその使用方法 |
| DE102014113482B4 (de) * | 2014-09-18 | 2019-01-03 | Bruker Daltonik Gmbh | Ionisierungskammer mit temperierter Gaszufuhr |
-
2017
- 2017-05-17 US US15/597,608 patent/US10147592B2/en active Active
- 2017-05-17 CA CA3024740A patent/CA3024740A1/en active Pending
- 2017-05-17 JP JP2019512942A patent/JP6889772B2/ja not_active Expired - Fee Related
- 2017-05-17 KR KR1020187036673A patent/KR102042436B1/ko not_active Expired - Fee Related
- 2017-05-17 CN CN201780044419.9A patent/CN109964541B/zh not_active Expired - Fee Related
- 2017-05-17 AU AU2017268310A patent/AU2017268310B8/en not_active Ceased
- 2017-05-17 WO PCT/US2017/033063 patent/WO2017201143A1/en not_active Ceased
- 2017-05-17 EP EP17800075.8A patent/EP3459323A4/en not_active Withdrawn
-
2018
- 2018-09-28 US US16/146,752 patent/US10395912B2/en active Active
-
2019
- 2019-08-26 US US16/551,056 patent/US10796895B2/en not_active Expired - Fee Related
-
2020
- 2020-09-18 US US17/025,430 patent/US11315778B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN109964541A (zh) | 2019-07-02 |
| WO2017201143A1 (en) | 2017-11-23 |
| US20200161117A1 (en) | 2020-05-21 |
| AU2017268310A8 (en) | 2022-12-08 |
| KR20190040135A (ko) | 2019-04-17 |
| US20210090872A1 (en) | 2021-03-25 |
| US10147592B2 (en) | 2018-12-04 |
| CN109964541B (zh) | 2021-01-01 |
| KR102042436B1 (ko) | 2019-11-08 |
| US11315778B2 (en) | 2022-04-26 |
| JP2019521366A (ja) | 2019-07-25 |
| AU2017268310B8 (en) | 2022-12-08 |
| US10395912B2 (en) | 2019-08-27 |
| US20170338092A1 (en) | 2017-11-23 |
| EP3459323A1 (en) | 2019-03-27 |
| US20190189416A1 (en) | 2019-06-20 |
| US10796895B2 (en) | 2020-10-06 |
| CA3024740A1 (en) | 2017-11-23 |
| AU2017268310A1 (en) | 2019-01-03 |
| EP3459323A4 (en) | 2020-01-01 |
| AU2017268310B2 (en) | 2022-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6889772B2 (ja) | 噴霧チャンバ及びそれらを利用する方法 | |
| Yin et al. | Recent advances in single-cell analysis by mass spectrometry | |
| Radley et al. | A common substrate for prefrontal and hippocampal inhibition of the neuroendocrine stress response | |
| EP2216396B1 (en) | Method of capturing cell fluid and analyzing components thereof while observing cell and system for capturing and analyzing cell fluid | |
| US12050221B2 (en) | Rapid native single cell mass spectrometry | |
| Jonas et al. | First in vivo testing of compounds targeting group 3 medulloblastomas using an implantable microdevice as a new paradigm for drug development | |
| JP2009539093A (ja) | 液体噴射による脱離イオン化のための方法及び装置 | |
| CN107314965B (zh) | 基于流式结合icp-ms单细胞蛋白检测的样本前处理方法 | |
| Sun et al. | Mechanisms involved in inflammatory pulmonary fibrosis induced by lunar dust simulant in rats | |
| Sun et al. | Monitoring AuNP dynamics in the blood of a single mouse using single particle inductively coupled plasma mass spectrometry with an ultralow-volume high-efficiency introduction system | |
| Dong et al. | High-efficiency miniaturized ultrasonic nebulization sample introduction system for elemental analysis of microvolume biological samples by inductively coupled plasma quadrupole mass spectrometry | |
| Xu et al. | Mass spectrometry-based techniques for single-cell analysis | |
| Hormigo et al. | Direct and indirect nigrofugal projections to the nucleus reticularis pontis caudalis mediate in the motor execution of the acoustic startle reflex | |
| Guo et al. | Investigation of calcium variations in single cells and the impact of Yoda1 on osteocytes by ICP-OES | |
| Miyashita et al. | Single cell analysis by using ICP-MS | |
| CN107944672A (zh) | 一种冬虫夏草使用风险性评估的新方法 | |
| Du et al. | High-throughput metabolomic method based on liquid chromatography: high resolution mass spectrometry with chemometrics for metabolic biomarkers and pathway analysis to reveal the protective effects of baicalin on thyroid cancer | |
| Shi et al. | N-Acetylcysteine-Capped TLQP21-Containing Au Nanocages Alleviate Depression in Mice | |
| Perry et al. | ICP-MS method for the determination of platinum in suspensions of cells exposed to cisplatin | |
| Nikravesh et al. | Platelet-derived microparticles enhance Ara-C-induced cell death in acute lymphoblastic leukemia (Nalm-6) | |
| He et al. | ICP‐MS for Single‐Cell Analysis in Metallomics | |
| New et al. | Detection and assessment of co‐association in inhalable drug particles using aerosol time‐of‐flight mass spectrometry | |
| Tanuma et al. | Imaging of cisplatin in single cancer cell and visualizing its mechanism of action by FIB-TOF-SIMS | |
| Wilson | Measurement of Nanoparticle Size Distributions and Number of Nanoparticles Per Volume by Inductively Coupled Plasma Mass Spectrometry | |
| Abduljabbar | Bio-imaging and serum analysis of zinc and other trace elements in a study of age-related diseases using inductively-coupled plasma mass spectrometry |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190206 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200518 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200518 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20200601 |
|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20200707 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200714 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20201013 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20201211 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210113 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210323 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210420 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210521 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6889772 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |